Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P42574 (
caspase-3
)
45,978
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Mice that lack
caspase-3
, which functions in apoptosis, were generated by gene targeting and shown to undergo hearing loss. The ABR threshold of the
caspase-3
(-/-) mice was significantly elevated compared to that of
caspase-3
(+/+) mice at 15 days of age and was progressively elevated further by 30 days. Distortion product otoacoustic emissions were not detectable in
caspase-3
(-/-) mice at 15 days of age.
Caspase-3
(-/-) mice exhibited marked degeneration of spiral ganglion neurons and a loss of inner and outer hair cells in the cochlea at 30 days of age, although no such changes were apparent at 15 days. The degenerating neurons manifested features, including cytoplasmic vacuolization, distinct from those characteristic of apoptosis. Spiral ganglion neurons and cochlear hair cells thus appear to require
caspase-3
for survival but not for initial development. The mapping of both the human
caspase-3
gene and the locus responsible for an autosomal dominant, nonsyndromic form of hearing loss (
DFNA24
) to chromosome 4q35 suggests that the
caspase-3
(-/-) mice may represent a model of this human condition.
...
PMID:Deafness due to degeneration of cochlear neurons in caspase-3-deficient mice. 1137 83